Credo Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 15.50 Cr
- Paid Up Capital ₹ 13.50 Cr
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 29.54 Cr
- Revenue Growth 22.08%
- Profit Growth 87.64%
- Ebitda 69.22%
- Net Worth 35.06%
- Total Assets 9.08%
About Credo Life Sciences
Credo Life Sciences Private Limited (CLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 July 2014 and has a history of Ten years and seven months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.50 Cr and a paid-up capital of Rs 13.50 Cr.
The company currently has active open charges totaling ₹29.54 Cr.
Siva Aluru, Aluru Krishna, and Kandru Madhavarao serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2014PTC112849
- Company No.
112849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Credo Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siva Aluru  | Managing Director | 03-Jul-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aluru Krishna | Director | 03-Jul-2014 | Current |
| Kandru Madhavarao | Director | 01-Apr-2015 | Current |
Financial Performance of Credo Life Sciences.
Credo Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.08% increase. The company also saw a substantial improvement in profitability, with a 87.64% increase in profit. The company's net worth Soared by an impressive increase of 35.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Credo Life Sciences?
In 2024, Credo Life Sciences had a promoter holding of 84.17% and a public holding of 15.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Credo Pharma Private LimitedSiva Aluru, Aluru Krishna and 1 more are mutual person
Auctus Life Sciences LlpSiva Aluru and Aluru Krishna are mutual person
Charges (Loans)
₹29.54 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 29.19 Cr
- Hdfc Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2024 | Indian Bank | ₹2.15 Cr | Open |
| 03 Jan 2023 | Hdfc Bank Limited | ₹3.50 M | Open |
| 31 Oct 2016 | Indian Bank | ₹27.04 Cr | Open |
How Many Employees Work at Credo Life Sciences?
Credo Life Sciences has a workforce of 204 employees as of Feb 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Credo Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Credo Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.